WebMesna and its dimer, dimesna, are coadministered for mitigation of ifosfamide- and cisplatin-induced toxicities, respectively. Dimesna is selectively reduced to mesna in the kidney, producing its protective effects. In vitro screens of uptake and efflux transporters revealed saturable uptake by renal organic anion transporters OAT1, OAT3, and OAT4. WebPharmacokinetics and pharmacodynamics of mesna-mediated plasma cysteine depletion. Cellular glutathione (GSH) levels are related to the resistance of tumor cells …
Mesna - an overview ScienceDirect Topics
Web10 : mL/min; hence, dose of mesna will consequently be reducedFrom what is known about the pharmacokinetics and mechanism of action of mesna, its availability in the urinary tract depends on renal functionIn the case of completely anuric patients (extremely rare) neither cyclophosphamide nor its metabolites should appear in the urinary tract: the use of … WebIf there is any risk of cyclophosphamide or its metabolites entering the urinary tract, mesna should probably be given to prevent urothelial toxicityLimited kinetic information would … foodxervices inc pte ltd logo
Influence of mesna on the pharmacokinetics of cisplatin …
Web30 dec. 1988 · Mesna is a thiol compound, i.e., a sulfhydryl (SH) group-containing organic compound. Hypersensitivity reactions to Mesna and … WebMesna is a thiol compound designed to function as a regional detoxificant of urotoxic oxazaphosphorine cytostatics such as ifosfamide. The drug is rapidly oxidized in the … WebAbstract Purpose: To compare the pharmacokinetics of the approved I.V. (intravenous) mesna regimen and an investigational I.V.-oral regimen that could be used in outpatients who receive ifosfamide. Patients and methods: The I.V. regimen consisted of three I.V. mesna doses given at 0, 4, and 8 hours after ifosfamide administration. electric stove with warmer drawer